Easton Pharmaceuticals (Easton Pharmaceuticals) Additional Paid-In Capital : $46.60 Mil(As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Easton Pharmaceuticals Additional Paid-In Capital?

Easton Pharmaceuticals's quarterly additional paid-in capital stayed the same from Mar. 2021 ($46.60 Mil) to Jun. 2021 ($46.60 Mil) and stayed the same from Jun. 2021 ($46.60 Mil) to Sep. 2021 ($46.60 Mil).

Easton Pharmaceuticals's annual additional paid-in capital increased from Dec. 2018 ($46.24 Mil) to Dec. 2019 ($46.60 Mil) but then stayed the same from Dec. 2019 ($46.60 Mil) to Dec. 2020 ($46.60 Mil).

Easton Pharmaceuticals Additional Paid-In Capital Historical Data

The historical data trend for Easton Pharmaceuticals's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easton Pharmaceuticals Additional Paid-In Capital Chart

Easton Pharmaceuticals Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec18

Dec19

Dec20

Additional Paid-In Capital

Get a 7-Day Free Trial

29.02

33.23

46.24

46.60

Easton Pharmaceuticals Quarterly Data
	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21
Additional Paid-In Capital	Get a 7-Day Free Trial															46.60	46.60	46.60	46.60	46.60

Easton Pharmaceuticals Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Easton Pharmaceuticals Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Easton Pharmaceuticals's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Easton Pharmaceuticals (Easton Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Easton Pharmaceuticals Inc (OTCPK:EAPH) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Bloor Street East, Suite 3500, Toronto, ON, CAN, M4W 1A8

Website

http://www.eastonpharmaceuticalsinc.com

Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.